COVID 19 pandemic is here. What to expect?

MARCH 23, 2020

Upcoming / RECENT Talks

COVID 19 pandemic is here. What to expect?

with Dr. Steven Pergam

March 26, 2020, 1:30 PM ET

RSVP

COVID 19 is now a global pandemic.The cases of coronavirus are increasing rapidly across the world with the count crossing 349,980 globally and increasing every day. The virus, which originated from China, has rapidly spread to about 160 countries.This is a critical time for information, support and reassurance that science and evidence can offer. We are talking to infectious disease expert Dr. Steven Pergam on where we stand and what to expect in terms of safety for immunocompromised patients, effectiveness of social distancing, preparing and responding to the pandemic in our daily lives.

Panelists

Dr Steven Pergam

Gary Petersen

Jack Aiello

Cynthia Chmielewski

Yelak Biru

Dr. Laurence Klotz

Mar 24, 2020, 10 AM ET

RSVP

CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers. It works by delivering a radioactive, toxic compound directly to tumor cells, while limiting exposure to healthy cells. CLR 131 was granted Orphan Drug designation for the treatment of multiple myeloma by both the U.S. and the European Commission. We are talking to Dr. Sikander Ailawadhi, the lead investigator on several CLR 131 trials, to get his perspective on the potential and future of CLR 131 as an important addition to myeloma treatments.

Panelists

Dr. Sikander Ailawadhi

Gary Petersen

Jack Aiello

Cynthia Chmielewski

Shweta Mishra

Mar 10, 2020, 12 PM ET

LISTEN

Brain tumors can be among the most challenging cancers to treat. The blood-brain barrier, a natural defense mechanism that shields the brain from harm can also prevent cancer treatments from reaching tumors. However, immunotherapy, precision medicine, and the other new approaches to treatments have been able to get through these barriers and effectively reach tumors. We are discussing the latest in brain tumor research and treatment with neuro-oncologist Dr. Nancy Bush from UCSF Helen Diller Family Comprehensive Cancer Center.

Panelists